This message contains images. If you don't see images, click here to view.
Advertise in this news brief.



Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit |  Histology Marketplace:     

Home   History   Meeting Calendar   Career Center   Certification   Contact Us    



 




NSH NEWS

2014 CFA Culling Memorial Lecturer announced for 40th Annual Symposium/Convention
NSH
The NSH Convention Committee is proud to announce the selection of Anna D. Barker, Ph.D., co-director, Complex Adaptive Systems; director and co-founder, National Biomarker Development Alliance; professor, School of Life Sciences Arizona State University and former deputy director of the National Cancer Institute. Dr. Barker's lecture titled, "Is Personalized (Molecular Based) Medicine Really Achievable in the Absence of Robust and Clinically Relevant Biomarkers?", will discuss the major challenges we face as we attempt to capitalize on what is increasingly characterized as an emerging era of "big data" in biomedicine. Learn more.

The C.F.A. Culling Memorial Lecture is an annual event sponsored by Poly Scientific R&D in honor of a dedicated scientist and friend of the Society, professor Charles Culling. Professor Culling's contributions to the field of histochemistry, particularly carbohydrates, are universally recognized through his textbook titled Handbook of Histopathological Technique. He had more than 80 publications. Throughout his work, he always retained a very practical approach to medical research due to his early technical training. He was one of the few with only technical training to become a full professor at the University of British Columbia.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article




TOP STORIES


Lawmakers push FDA oversight of lab tests
The Hill
Democratic senators are pressing the Obama administration to give the Food and Drug Administration authority to regulate laboratory tests used to detect high-risk conditions like cancer and Lyme disease. Sen. Ed Markey, D-Mass., and other lawmakers wrote to the Office of Management and Budget, asking it to quickly release a draft guidance allowing the FDA to regulate so-called Laboratory Developed Tests, used to diagnose serious diseases.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SPONSORED CONTENT


New study of fruit fly genome reveals complexity of RNA and provides a model for studying mechanisms for hereditary diseases in humans
Dark Daily
Scientists have teased another level of information out of the genome. This time, the new insights were developed from studies of the fruit fly's transcriptome. This knowledge will give pathologists another channel of information that may be useful in developing assays to support more precise diagnosis and therapeutic decisions.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Empowering Science with Color Integrity
Datacolor CHROMACAL™ standardizes color reproduction in digital brightfield images.
• Delivers a consistent, reliable basis for evaluation, communication, quantification, documentation and publication
• Includes image and monitor calibration software, along with a proprietary color calibration slide
• Integrates into existing imaging workflow
• Compatible with most microscopes, scientific cameras and acquisition software
LEARN MORE
 


The contamination stops here with 3M's express salmonella testing
StarTribune
Salmonella bacteria, which cause sometimes fatal food poisoning, have survived 50 years of scientific efforts to wipe them out. 3M Co. is part of the next-best solution: Trying to prevent salmonella contamination at food processing plants by using detective work to identify contaminated products before they are shipped to customers.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Using nanoparticles to enhance chemotherapy
Controlled Environments
University of Georgia researchers have developed a new formulation of cisplatin, a common chemotherapy drug, that significantly increases the drug's ability to target and destroy cancerous cells. Cisplatin may be used to treat a variety of cancers, but it is most commonly prescribed for cancer of the bladder, ovaries, cervix, testicles and lung. It is an effective drug, but many cancerous cells develop resistance to the treatment.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Consumers may soon have a home blood collection kit that allows them to monitor and quantify damage to their DNA
Dark Daily
It might be coming soon to a pharmacy or other retail store near you: a medical laboratory test kit allows consumers to test themselves for damaged DNA. This bold new world for genetic testing is the vision of a new company in San Francisco called Exogen Biotechnology.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  NanoMolds™ Save Time, Energy & Money
NanoMolds produce paraffin blocks much quicker and release easier than traditional methods – without the use of messy chemical mold release.
  • Requires less cleaning
  • Easier & Faster block
  •     release
  • Faster creation of the block
  • Available in 5 popular sizes
  • Call Sakura at 800-725-8723 for more information
     


    Inverted microscope suited for cell culture work
    Laboratory Equipment
    Leica Microsystems' DMi1 is an entry-level inverted microscope with functions specifically necessary for routine lab work. It enables cell biologists to check and document cell and tissue cultures within sec. Its ease-of-use and efficient operation make it an excellent choice for routine laboratory work and training. Combining high performance and affordability, the microscope is equipped with LED illumination that provides constant color temperature with up to 20 years.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    PRODUCT SHOWCASE
      ergoCentric Laboratory Seating

    Visit LabStorage System’s updated website to view details about this new laboratory seating with specially formulated Infection Control coating. Non-porous and easily disinfected, this moisture proof coating is anti-bacterial, anti-fungal and stain resistant. more
     


    5 tips to foolproof your antibody-based experiments
    Genetic Engineering & Biotechnology News
    A faulty antibody is not always obvious, but using one unknowingly will drain any lab's resources, regardless of size and funding. Acting on the suspicion that one of their pancreatic cancer-related antibodies was faulty, a research group in Toronto launched a two-year, $500,000 investigation to discover that what they thought was an antibody against CUZD1 was actually against CA125.1 It is easy to assume that a recently purchased antibody or one borrowed from a labmate has been validated and works as intended, but there are no universal guidelines or standards for antibody production and validation.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE




    Alzheimer's predictive blood test takes a step in lab
    CBC News
    A set of protein markers could help predict the onset of Alzheimer's to help improve screening in clinical trials, a British scientist says. In a study published Tuesday in Alzheimer's & Dementia: The Journal of the Alzheimer's Association, researchers said they found a set of 10 proteins in the blood that seem predictive.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    TRENDING ARTICLES
    Missed last week's issue? See which articles your colleagues read most.

        Researchers seeking 'biomarkers' that could help prevent Alzheimer's (The Spokesman-Review)
    Workflow Analysis webinar presented by Olga Kochar, MS, GWU Hospital — July 10 (NSH)
    Dr. Beck Weathers — miracle on Everest (NSH)
    Mayo Clinic and Whole Biome announce collaboration to research the role of the human microbiome in women's diseases using unique medical lab tests (Dark Daily)

    Don't be left behind. Click here to see what else you missed.




    New arenas in cell-based regenerative therapies for SCI
    By Dr. Afsaneh Motamed-Khorasani
    Traumatic spinal cord injury, or SCI, imposes enormous financial, emotional and psychological burdens on the patients, their families and the society in which they live. Despite years of research, treatments for paralysis are limited to steroid administration in high doses, acute surgical intervention to stabilize and decompress the spinal cord or rehabilitative care. Over the course of the past decade, tremendous progress has been observed in our level of understanding of events caused by SCI.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


     

    Under the Microscope
    Colby Horton, Vice President of Publishing, 469.420.2601
    Download media kit

    Ashley Whipple, Senior Content Editor, 469.420.2642   
    Contribute news

    This edition of Under the Microscope was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
    Recent issues
    July 2, 2014
    June 30, 2014 Blast
    June 25, 2014
    June 18, 2014



    7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063